Aidan Dineen
Senior Director, HEOR
Expertise:
Aidan Dineen, PhD is a Senior Director within EVERSANA’s Value & Evidence team with nearly a decade of experience supporting pharmaceutical and medical device manufacturers in the development of evidence strategies that enable successful commercialization and market access.
Drawing on a multidisciplinary scientific background and extensive HEOR expertise, he specializes in integrated evidence generation planning across all stages of the product lifecycle. Aidan partners with cross-functional stakeholders to design evidence strategies that align clinical, economic, payer, and patient evidence needs. His experience spans global evidence generation programs, health technology assessment (HTA) submissions, economic modelling, burden of illness research, value communication, and real-world evidence planning. He has contributed to more than 20 reimbursement submissions across Canada and the United Kingdom and has supported evidence strategies across a broad range of therapeutic areas, including oncology, nephrology, immunology, neurology, respiratory disease, gastroenterology, rare diseases, and cardiovascular health.
Prior to joining EVERSANA, Aidan spent 10 years in academic research focused on molecular genetics, immune-mediated diseases, and genome editing technologies. He holds a PhD in Molecular and Medical Genetics from the University of Calgary, an MSc in Biology from McMaster University, and an Honours BSc in Developmental Biology from the University of Toronto.
Articles by Aidan Dineen
The Hidden Cost of Late Evidence Planning
Many pharmaceutical teams cross the regulatory finish line only to hit a wall: market access demands a head-to-head comparison or real-world data that simply doesn’t exist. Treating Evidence Generation Planning (EGP) as a reactive, late-stage checklist rather than an early strategic lever is a costly mistake. When evidence planning is framed too narrowly around regulatory approval, companies […]
Unlocking Insights: EVERSANA’s Value & Evidence Team’s Impact on Economic and Healthcare Resource Utilization Outcomes in Robotic vs. Manual Total Knee Arthroplasty
The use of robotics in surgical procedures is becoming increasingly popular, with the potential to reshape the landscape of modern surgery. In total knee arthroplasty (TKA), the increased adoption of robotics has improved clinical outcomes, including increased precision and standardization compared to the manual procedure. While these findings have been well documented, evidence of the […]